**Question:** A lady with abdominal mass was investigated. On surgery, she was found to have bilateral ovarian masses with smooth surface. On microscopy they revealed mucin-secreting cells with signet ring shapes. Most probable diagnosis is:

A. Endometrioid carcinoma
B. Serous carcinoma
C. Luteinized uterine dermoid cyst
D. Mucinous borderline tumor

**Correct Answer:** D. Mucinous borderline tumor

**Core Concept:** Mucin-secreting tumors of the ovary

**Why the Correct Answer is Right:**

The correct answer is D. Mucinous borderline tumor because the presence of mucin-secreting cells with signet ring shapes in the ovarian masses indicates a tumor with mucin production. This is characteristic of mucinous tumors, which are further classified into benign, borderline, and malignant subtypes based on the degree of cellular atypia and the potential for malignant behavior.

**Why Each Wrong Option is Incorrect:**

A. Endometrioid carcinoma (Option A): This is a type of epithelial ovarian cancer that arises from the endometrial cells, not mucin-secreting cells. The presence of signet ring cells is not a defining feature of endometrioid carcinoma.

B. Serous carcinoma (Option B): This is another type of ovarian cancer, but it originates from serous surface epithelium and does not typically display signet ring cells.

C. Luteinized uterine dermoid cyst (Option C): This is a benign tumor of the ovary, usually containing functional corpus luteum and follicular remnants. The presence of signet ring cells is not consistent with this diagnosis.

D. Mucinous borderline tumor (Correct Answer): This is a low-grade ovarian tumor characterized by mucin production and cellular atypia. The presence of signet ring cells is a key feature of this diagnosis.

**Clinical Pearl:**

Mucinous borderline tumors are relatively rare and account for around 10-15% of all ovarian tumors. They are often discovered incidentally during surgery or on imaging studies due to the presence of large, cystic masses. Treatment options include surgery, typically with preservation of reproductive function, and follow-up monitoring based on the risk of recurrence.

**Why it Matters for Clinical Practice:**

Recognizing mucinous borderline tumors is crucial for appropriate management and prognosis of these patients. Although these tumors are generally considered indolent, they can recur in up to 10-20% of cases, and follow-up is essential to monitor for potential progression to a more aggressive mucinous borderline tumor or invasive carcinoma. Additionally, accurate diagnosis allows for appropriate surgical approach, ensuring preservation of reproductive function while still addressing the tumor.